Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: Systemic, Mucosal & Passive Immunity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-03-09 |
| Study Made Public: | 2014-12-22 |
Title
Immunogenicity and efficacy of rhFLSC vs gp120 vaccination in the rhesus macaque/SHIV model
Description
CAVD 354 is a non-human primate study of protein and adjuvant regimens, comparing rhFLSC antigen versus gp120 in RC529 and Iscomatrix adjuvants.
Sign in to see full information about this study and to download study data.
Products
rhFLSC Protein SHIV162p3 RC529 Iscomatrix gp120 NoneIntegrated data
BAMA
Non-integrated data
No non-integrated data is available for this study.